Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001268
Filing Date
2025-05-14
Accepted
2025-05-14 16:14:58
Documents
79
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ctso-20250331x10q.htm   iXBRL 10-Q 1280464
2 EX-31.1 ctso-20250331xex31d1.htm EX-31.1 18714
3 EX-31.2 ctso-20250331xex31d2.htm EX-31.2 16574
4 EX-32.1 ctso-20250331xex32d1.htm EX-32.1 7073
5 EX-32.2 ctso-20250331xex32d2.htm EX-32.2 7060
  Complete submission text file 0001410578-25-001268.txt   7473904

Data Files

Seq Description Document Type Size
6 EX-101.SCH ctso-20250331.xsd EX-101.SCH 60904
7 EX-101.CAL ctso-20250331_cal.xml EX-101.CAL 71476
8 EX-101.DEF ctso-20250331_def.xml EX-101.DEF 236506
9 EX-101.LAB ctso-20250331_lab.xml EX-101.LAB 478740
10 EX-101.PRE ctso-20250331_pre.xml EX-101.PRE 423501
82 EXTRACTED XBRL INSTANCE DOCUMENT ctso-20250331x10q_htm.xml XML 1270676
Mailing Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540 973-329-8885
Cytosorbents Corp (Filer) CIK: 0001175151 (see all company filings)

EIN.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36792 | Film No.: 25945678
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)